Best Health and Medical Grants in Wyoming

The FY 2027 Service Area Competition (SAC) aims to enhance health services in underserved communities across the U.S. and its territories. This funding opportunity supports comprehensive preventive and primary health care delivery. Each SAC announcement details service areas available for competition, with potential additional areas announced throughout the year. This initiative is crucial for ensuring continuous access to quality health care for vulnerable populations.

The FY 2027 Service Area Competition (SAC) funding aims to enhance healthcare access in underserved communities across the U.S. by providing grants for comprehensive primary and preventive health services. This initiative addresses essential health needs through competitive funding opportunities, ensuring that health centers can effectively serve their designated areas. Additional service areas may be announced as needed if current centers are unable to continue their operations, thus maintaining service continuity.

The Leadership Education in Adolescent Health (LEAH) Program, funded by the US HHS: Health Resources & Services Administration, aims to enhance the quality of care for adolescents and young adults. By establishing graduate training programs, LEAH prepares healthcare professionals to effectively address chronic disease prevention and improve access to team-based healthcare services for this population, ultimately fostering better health outcomes and empowering future leaders in adolescent health.

The NIH's Investigator-Focused Award (Parent R35) aims to support research programs for investigators at all career stages, including Early Stage Investigators. This funding provides stability and freedom in research, allowing for innovative and ambitious studies without the constant pressure of securing new grants. Key benefits include flexibility in research direction, opportunities to tackle significant questions, and a greater potential for scientific breakthroughs, fostering a robust research environment.

The Society of Interventional Radiology Foundation

SIR Foundation is a scientific foundation dedicated to fostering research in interventional radiology for the purposes of advancing scientific knowledge, increasing the number of skilled investigators, and developing innovative therapies that lead to improved patient care and quality of life. The foundation is committed to fostering the development and enhancement of innovative, minimally invasive, image-guided therapies from inception to mature clinical application and to conduct educational programs in the service of its mission.

Giving Circle for the Advancement of Women (GCAW) Award

Provide career development opportunities for women in interventional radiology. GCAW is dedicated to engaging all generations of women in interventional radiology through the power of community philanthropy.

Cherokee Nation Foundation

The Cherokee Nation Foundation is a nonprofit organization serving the Cherokee Nation, a federally recognized tribe of more than 470,000 citizens. Its mission is to provide educational opportunities to Cherokee students so they can reach their full potential. The Cherokee Nation Foundation is a tax-exempt charitable organization under Section 501(c)(3) of the Internal Revenue Code.

Cherokee Nation Allied Health Scholarship

The purpose of the Cherokee Nation Allied Health Scholarship is to provide financial assistance to Cherokee Nation citizens pursuing college degrees in health care fields to support their readiness to contribute to and grow within the Cherokee Nation reservation labor market. This scholarship is competitive and subject to availability of funding.

The foundation also offers a Nursing Scholarship and if funding allows, scholarships will be available for degrees in health fields other than nursing to meet any current workforce need in the Cherokee Nation Health Services department.

The Limited Competition for High Impact Specialized Innovation Programs aims to enhance clinical and translational science by funding unique capabilities and addressing critical gaps through the Clinical and Translational Science Award (CTSA) Program. This initiative fosters collaboration across a national network of academic medical centers, facilitating the transition of scientific discoveries into impactful health interventions. Applications are peer-reviewed, ensuring funding is directed towards the most promising proposals.

The Clinical and Translational Science Awards (CTSA) Program aims to expedite the integration of scientific discoveries into effective health interventions. By providing essential infrastructure and support to academic medical centers, the program fosters innovative research approaches that enhance translational science. The Collaborative and Innovative Acceleration Award under this initiative seeks to promote partnerships that accelerate the development of new treatments, ultimately improving health outcomes for diverse populations.

The Limited Competition Research Education Program for the Clinical and Translational Science Awards Program aims to enhance the training of a workforce to meet the nation's biomedical and clinical research needs. It supports educational activities that facilitate the translation of scientific discoveries into practical health interventions. Funded by the NIH, this program invites applications from eligible organizations, and only those with meritorious proposals will be considered for funding.

The Next Generation of the Clinical and Translational Science Awards Program Trial Innovation Network aims to tackle significant challenges in multi-center clinical trials. By enhancing trial efficiency and safety through innovative solutions, the initiative seeks to improve the design and execution of these studies. Key areas of focus include safety monitoring tools, trial leader mentorship, and advancements in digital health technologies. This program invites eligible organizations to apply for funding to promote groundbreaking clinical research.

The Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant aims to enhance clinical and translational science training by supporting programs that prepare predoctoral and postdoctoral researchers. This initiative, funded by the NIH, focuses on translating scientific discoveries into effective health interventions. Eligible institutions will be invited to apply, and only high-quality applications will be considered for funding, ensuring a robust peer-review process.

The Limited Competition: Institutional Mentored Research Career Development Program aims to enhance the CTSA Program by fostering the development of postdoctoral fellows and junior faculty. This initiative focuses on training individuals for independent clinical and translational science careers, ensuring they are well-prepared for research engagement. Funded by the NIH, the program supports a national network of academic centers to facilitate the transition of scientific discoveries into practical health solutions.

The Clinical and Translational Science Award (CTSA) Program aims to enhance the translation of scientific research into effective health interventions by establishing a national network of academic medical centers. This program supports integrated research and training environments for clinical and translational science, promoting the development of innovative methods and technologies. The reissuance of the CTSA Notice of Funding Opportunity invites eligible organizations to apply, with peer-reviewed applications prioritized for funding.

Our Mission

Empower donors to fulfill their passions and dreams by establishing charitable vehicles designed to create a positive and enduring impact on Jewish Buffalo, Western New York and the World.

Dr. Louis Sklarow Award

The Dr. Louis Sklarow Award was established in 1995 in honor of prominent Buffalo Physician and State University of New York at Buffalo Medical School Graduate Dr. Louis Sklarow.

The award is given to an outstanding graduate of Jewish faith from the Jacob’s School of Medicine who has shown by character and medical accomplishment great promise in becoming a fine physician and a person most likely to make a contribution to mankind and bring honor to the Jacob’s School of Medicine.

The Louis Sklarow Memorial Fund continues to fund research for the treatment and cure of Down Syndrome, Alzheimer’s disease and cancer through research performed at the University of Buffalo, Roswell Park Comprehensive Cancer Center and other renown institutions.

The Discovery Gateway to Reproductive Health Innovation, established by the NICHD, aims to create a comprehensive knowledgebase to advance research on various reproductive health conditions like preeclampsia and infertility. This initiative will integrate clinical and multi-omic data to bridge critical knowledge gaps, enabling scientists to generate insights that could lead to new treatments and commercial products, thereby accelerating public-private partnerships and improving health outcomes.

The NIH is set to release a Notice of Funding Opportunity for early to definitive clinical trials across various biomedical fields. This initiative focuses on trials evaluating drugs, devices, and interventions that align with NIH's mission. Utilizing the R61/R33 funding mechanism, projects can span up to 7 years, supporting both planning and trial phases. Interested investigators are encouraged to prepare collaborative proposals, although applications are not currently being solicited.

The NLM Grants for Scholarly Works in Biomedicine and Health (G13) program invites applications to support the creation of book-length manuscripts and scholarly works that are vital for U.S. health professionals and scientists. This initiative aims to foster critical reviews and analytical syntheses that enhance understanding of biomedical and public health challenges, ultimately contributing valuable resources for education, research, and clinical practice.

The R21 Clinical Trial Not Allowed funding opportunity invites innovative research to develop and enhance research models and biological materials vital for studying human health and diseases. It emphasizes the need for new approach methodologies (NAMs) to improve the identification of confounding factors in biomedical research. Projects should have broad applicability across multiple NIH Institutes, focusing on various body systems and disease categories, ensuring relevance to a wide range of health issues.

The National Institutes of Health (NIH) is continuing support for the Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT), which focuses on clinical trials and biomarker validation studies for neurological disorders. This initiative aims to foster innovation in neurotherapeutics by providing essential infrastructure and expertise. The program encourages the establishment of Clinical Coordinating Centers (CCC) and Data Coordinating Centers (DCC) to enhance collaborative efforts. Note that applications are not currently being solicited.

The NIH Director's Transformative Research Award encourages innovative research that challenges conventional ideas. This award supports bold scientists and teams aiming to create groundbreaking technologies and new clinical approaches, ultimately transforming scientific paradigms. As part of the NIH Common Fund's High-Risk, High-Reward Research Program, it seeks to fund high-impact projects that have the potential to significantly advance science and technology.

The NIH Director's Early Independence Award empowers exceptional early-career researchers to embark on independent research careers immediately after their doctoral degree or post-graduate clinical training. This initiative accelerates the transition to independence, promoting innovative research across various fields aligned with the NIH mission. As part of the NIH Common Fund's High-Risk, High-Reward Research Program, it encourages groundbreaking studies that could significantly advance health-related knowledge.

The NIH Director's Pioneer Award (DP1) encourages innovative research by funding exceptional scientists. This award is designed for groundbreaking projects that diverge from the investigator's current work and address significant scientific challenges relevant to the NIH mission. Applications are invited across all NIH-relevant fields, promoting high-risk, high-reward research that could transform our understanding of critical scientific areas.

The NIH Director's New Innovator Award supports creative early-stage investigators pursuing innovative research with transformative potential for science relevant to the NIH mission. Applications are encouraged across all NIH-related fields, enhancing support for emerging talent. This award is part of the NIH Common Fund's High-Risk, High-Reward Research Program, which aims to cultivate groundbreaking research and foster the next generation of scientists.

About BHOF

For 40 years, the Bone Health & Osteoporosis Foundation (BHOF) has been committed to preventing osteoporosis and promoting awareness about bone health. Learn more about our organization.

Awards

Robert F. Gagel, M.D. Community Leadership Award

The Robert F. Gagel, M.D. Community Leadership Award recognizes a healthcare professional who has made outstanding contributions to improving osteoporosis care and increasing community awareness about bone health. This award will be presented annually to a healthcare professional residing and working in the United States or its territories.

The Executive Committee of the Bone Health and Osteoporosis Foundation’s (BHOF’s) Board of Trustees will review nominations and select the recipient.

The award winner will be notified and announced in May, in recognition of Osteoporosis Awareness and Prevention Month. The recipient will receive a plaque and a financial award (currently $1,000) to support community service efforts initiatives related to osteoporosis and bone health.

About Us

Our Mission

The Marfan Foundation drives research, education and support – and builds community – to improve outcomes, save lives and empower all people to thrive who are living with Marfan, Loeys-Dietz, Vascular Ehlers-Danlos syndromes, and related genetic aortic and vascular conditions.

Our Vision

Quality of life, longevity, and cures for all people with genetic aortic and vascular conditions.

Innovators Award

This is for faculty investigators for $100,000 over 2 years ($50,000 per year), to explore an innovative concept in “translational” science that has applicability to improving human health. Examples could include fundamental research, diagnostic tests, biomarkers, biomedical engineering advances, and imaging advances. Collection of data for improved evidence-based medical guidance are of great interest.

About Us

Our Mission

The Marfan Foundation drives research, education and support – and builds community – to improve outcomes, save lives and empower all people to thrive who are living with Marfan, Loeys-Dietz, Vascular Ehlers-Danlos syndromes, and related genetic aortic and vascular conditions.

Our Vision

Quality of life, longevity, and cures for all people with genetic aortic and vascular conditions.

Career Development Award

The Career Development Award will support two-year $100,000 grants ($50,000 per year) in basic, translational, or clinical research studying any discipline involved in Marfan syndrome, Loeys-Dietz syndrome, Vascular Ehlers-Danlos syndrome, and other related conditions. This grant program is designed to support investigators early in their career to derive preliminary data in a key concept area that has high potential to lead to extended funding from NIH, EU, and other large research funding sources.

The National Institute on Minority Health and Health Disparities (NIMHD) is offering funding for innovative research aimed at improving health outcomes for Native Hawaiian and Pacific Islander populations. This grant will support preparatory and pilot activities that focus on understanding health disparities, testing interventions for chronic diseases, and promoting health behavior changes in collaboration with community partners. Projects should address critical health issues such as cancer, diabetes, and maternal health.